Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.
Vous n'êtes pas connecté
After undergoing mastectomies, breast cancer patients face years-long waits in the public system for “medically necessary” reconstructive surgery – or crippling out-of-pocket costs in the private system.
Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.
Researchers examine the association between patient-derived xenograft with recurrence and survival rates in triple negative breast cancer patients.
WEDNESDAY, Sept. 4, 2024 -- Plastic surgery patients who use marijuana also have elevated nicotine levels, according to a study published in the...
Breakthrough in triple-negative breast cancer diagnosis: New test improves early detection, offering better outcomes and personalized treatment...
Shorter-course radiation therapy is a more efficient and equally effective option for breast cancer patients compared to traditional longer...
FRIDAY, Sept. 6, 2024 -- Machine learning can identify patients who are at risk for persistent opioid use after surgery, according to a study...
Following surgery, doctors advised the model to undergo a mastectomy with radiation, chemotherapy and a breast reconstruction.
SATURDAY, Sept. 7, 2024 -- As a new federal regulation that requires mammography centers to tell their patients how dense their breasts are takes...
The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a better treatment for avoiding...
Delivering higher doses of radiation therapy in fewer sessions after medlinkbreast cancer surgery/medlink can significantly reduce side effects and